文献速递脑血管病

心房颤动患者的围手术期急性缺血性卒中

Perioperative Acute Ischemic Stroke in Patients with Atrial Fibrillation.
PubMed 文献 · Ann Neurol · 2023-05-26

本研究利用全国再入院数据库对2016至2019年择期手术的成年心房颤动患者进行全国性分析,共纳入1,045,293例,围手术期急性缺血性卒中发生率为0.70%。活动性癌症、肾衰竭、神经外科手术、心血管手术及较高的CHA2DS2VASc评分是围手术期急性缺血性卒中的显著危险因素,新评分系统(AUC=0.68)优于CHA2DS2VASc(AUC=0.60)。

要点

  • 择期手术的心房颤动患者围手术期急性缺血性卒中发生率为0.70%。
  • 活动性癌症、肾衰竭、神经外科手术、心血管手术及较高CHA2DS2VASc评分是显著危险因素。
  • 新评分系统(含手术类型和癌症)AUC=0.68,优于CHA2DS2VASc的AUC=0.60。

核心结论

  • 在心房颤动患者中,围手术期急性缺血性卒中风险随CHA2DS2VASc评分、活动性癌症以及心血管或神经外科手术而增加。
  • 需要开展研究以制定更好的策略来降低这些患者的围手术期急性缺血性卒中风险。

研究设计与样本

  • 利用全国再入院数据库进行的全国性分析,纳入2016至2019年择期入院的成年心房颤动患者,且有手术操作诊断相关组代码。
  • 共纳入1,045,293例患者,平均年龄71.5岁,女性占39.2%。
  • 采用逻辑回归模型识别危险因素,并开发结合CHA2DS2VASc的新评分系统。

主要发现

  • 在指数住院期间或出院后30天内,0.70%的患者发生围手术期急性缺血性卒中。
  • 活动性癌症(调整OR=1.58,95%CI 1.42-1.76)、肾衰竭(调整OR=1.14,95%CI 1.04-1.24)、神经外科手术(调整OR=4.51,95%CI 3.84-5.30)、心血管手术(调整OR=2.74,95%CI 2.52-2.97)及较高CHA2DS2VASc评分(每分调整OR=1.25,95%CI 1.22-1.29)是围手术期急性缺血性卒中的显著危险因素。
  • 新评分系统(结合手术类型和癌症)的AUC=0.68(95%CI 0.67-0.79),优于CHA2DS2VASc的AUC=0.60(95%CI 0.60-0.61)。

关键数值与推荐

  • 活动性癌症:调整OR=1.58,95%CI 1.42-1.76。
  • 肾衰竭:调整OR=1.14,95%CI 1.04-1.24。
  • 神经外科手术:调整OR=4.51,95%CI 3.84-5.30。
  • 心血管手术:调整OR=2.74,95%CI 2.52-2.97。
  • CHA2DS2VASc评分每增加1分:调整OR=1.25,95%CI 1.22-1.29。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anticoagulation therapy is commonly interrupted in patients with atrial fibrillation (AF) for elective procedures. However, the risk factors of acute ischemic stroke (AIS) during the periprocedural period remain uncertain. We performed a nationwide analysis to evaluate AIS risk factors in patients with AF undergoing elective surgical procedures. METHODS: Using the Nationwide Readmission Database, we included electively admitted adult patients with AF and procedural Diagnosis-Related Group codes from 2016 to 2019. Diagnoses were identified based on International Classification of Disease, 9th revision-Clinical Modification (ICD-10 CM) codes. We constructed a logistic regression model to identify risk factors and developed a new scoring system incorporating CHA2 DS2 VASc to estimate periprocedural AIS risk. RESULTS: Of the 1,045,293 patients with AF admitted for an elective procedure, the mean age was 71.5 years, 39.2% were women, and 0.70% had a perioperative AIS during the index admission or within 30 days of discharge. Active cancer (adjusted OR [aOR] = 1.58, 95% confidence interval [CI] = 1.42-1.76), renal failure (aOR = 1.14, 95% CI = 1.04-1.24), neurological surgery (aOR = 4.51, 95% CI = 3.84-5.30), cardiovascular surgery (aOR = 2.74, 95% CI = 2.52-2.97), and higher CHA2 DS2 VASc scores (aOR 1.25 per point, 95% CI 1.22-1.29) were significant risk factors for periprocedural AIS. The new scoring system (area under the receiver operating characteristic curve [AUC] = 0.68, 95% CI = 0.67 to 0.79) incorporating surgical type and cancer outperformed CHA2 DS2 VASc (AUC = 0.60, 95% CI = 0.60 to 0.61). INTERPRETATION: In patients with AF, periprocedural AIS risk increases with the CHA2 DS2 VASc score, active cancer, and cardiovascular or neurological surgeries. Studies are needed to devise better strategies to mitigate perioperative AIS risk in these patients. ANN NEUROL 2023;94:321-329.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Shu L, Jiang W, Xiao H, et al. Perioperative Acute Ischemic Stroke in Patients with Atrial Fibrillation. Ann Neurol. 2023. PMID: 37183768. doi:10.1002/ana.26678

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。